Accurate identification of HLA-B*15:02 allele by two-dimensional polymerase chain reaction

被引:2
|
作者
Zhu, Xueting [1 ]
Yu, Yang [1 ]
Zhang, Jun [1 ]
Zhan, Yuxia [1 ]
Luo, Guanghua [1 ]
Zheng, Lu [1 ]
机构
[1] Soochow Univ, Clin Med Res Ctr, Affiliated Hosp 3, Changzhou, Peoples R China
关键词
2D-PCR; HLA-B*15:02; Genotyping; STEVENS-JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; HLA CLASS-I; CUTANEOUS ADVERSE-REACTIONS; DRUG-REACTIONS; RISK-FACTOR; CARBAMAZEPINE; ASSOCIATION; HAN; POPULATION;
D O I
10.1016/j.cca.2023.117654
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: HLA-B*15:02 is highly associated with carbamazepine-induced SJS/TEN; however, there is no rapid and accurate detecting method. Here, we present a method to distinguish HLA-B*15:02 from 16 highly homologous HLA-B*15 alleles.Methods: The high-throughput two-dimensional polymerase chain reaction (2D-PCR) technology was employed to identify HLA-B*15:02 in two-tube reaction. And, 2D-PCR accuracy was verified by PCR-sequence based typing (PCR-SBT).Results: HLA-B*15:02 heterozygotes were identified by 14 melting valleys in the first tube reaction and none in the second, or by 13 melting valleys in the first tube reaction and one in the second. HLA-B*15:02 homozygote was identified by 13 melting valleys in the first tube reaction and none in the second. Three (0.16%) HLA-B*15:02 homozygotes and 84 (4.59%) HLA-B*15:02 heterozygotes were detected in 1830 samples of clinical general population without detecting 16 highly homologous alleles to HLA-B*15:02. The kappa test showed 100% coincidence between the 2D-PCR and PCR-SBT.Conclusions: 2D-PCR in two-tube reaction method for identifying HLA-B*15:02 was successfully established. Identification of HLA-B*15:02 is necessary prior to taking CBZ based on HLA-B*15:02 allele frequency.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] An interdigitated electrode biosensor platform for rapid HLA-B*15:02 genotyping for prevention of drug hypersensitivity
    Soraya, Gita V.
    Chan, Jianxiong
    Nguyen, Thanh C.
    Huynh, Duc H.
    Abeyrathne, Chathurika D.
    Chana, Gursharan
    Todaro, Marian
    Skafidas, Efstratios
    Kwan, Patrick
    BIOSENSORS & BIOELECTRONICS, 2018, 111 : 174 - 183
  • [22] rs144012689 is a highly specific representative marker of HLA-B*15:02 in the Chinese population
    Xi, Pei
    Wang, Hao
    Zhong, Zihua
    Liu, Shihui
    Tang, Jiaxuan
    Guo, Chunli
    Dai, Penggai
    PHARMACOGENOMICS, 2022, 23 (15) : 835 - 845
  • [23] Association between HLA-B*15:02 and oxcarbazepine-induced cutaneous adverse reaction: a meta-analysis
    Liu, Yiwei
    Yu, Yuncui
    Nie, Xiaolu
    Zhao, Libo
    Wang, Xiaoling
    PHARMACOGENOMICS, 2018, 19 (06) : 547 - 552
  • [24] Is universal HLA-B*15:02 screening a cost-effective option in an ethnically diverse population? A case study of Malaysia
    Chong, H. Y.
    Mohamed, Z.
    Tan, L. L.
    Wu, D. B. C.
    Shabaruddin, F. H.
    Dahlui, M.
    Apalasamy, Y. D.
    Snyder, S. R.
    Williams, M. S.
    Hao, J.
    Cavallari, L. H.
    Chaiyakunapruk, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (04) : 1102 - 1112
  • [25] Cost-effectiveness of HLA-B*15:02 screening in Malaysia
    Plumpton, C.
    Hughes, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (04) : 904 - 905
  • [26] The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome
    Bellon, Teresa
    Ramirez, Elena
    Borobia, Alberto M.
    Lerma, Victoria
    Moreno-Hidalgo, Miguel A.
    Laosa, Olga
    Aramburu, Jose A.
    Gonzalez-Herrada, Carlos
    de Abajo, Francisco J.
    PHARMACOGENOMICS, 2016, 17 (06) : 541 - 545
  • [27] Association between HLA-B*15:02 and carbamazepine induced severe cutaneous adverse drug reactions in Myanmar
    Khor, Amy Hui-Ping
    Aye, Seinn Mya Mya
    Lim, Kheng-Seang
    Aung, Yan Lynn
    Aye, Yin Minn
    Ohnmar
    Thit, Win Min
    Tan, Chong-Tin
    Ng, Ching-Ching
    NEUROLOGY ASIA, 2017, 22 (03) : 283 - 285
  • [28] Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China
    He, Xiao-Jing
    Jian, Ling-Yan
    He, Xiao-Lin
    Wu, Yan
    Xu, Yuan-Yuan
    Sun, Xiao-Jie
    Miao, Li-Yan
    Zhao, Li-Mei
    PHARMACOLOGICAL REPORTS, 2013, 65 (05) : 1256 - 1262
  • [29] Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand
    Rattanavipapong, Waranya
    Koopitakkajorn, Tanunya
    Praditsitthikorn, Naiyana
    Mahasirimongkol, Surakameth
    Teerawattananon, Yot
    EPILEPSIA, 2013, 54 (09) : 1628 - 1638
  • [30] Association of the HLA-B*15:02 allele with pure cervical lymphadenopathy induced by carbamazepine and oxcarbazepine: A case report and literature review
    Liu, Hailing
    Lan, Song
    Liu, Detian
    Xu, Meng
    Yi, Yonghong
    Li, Bingmei
    Liu, Xiaorong
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 (02) : 348 - 351